Center for Vaccine Development and Global Health

Center for Vaccine Development and Global Health
Name	Center for Vaccine Development and Global Health
Established	19XX
Location	Baltimore, Maryland, United States
Affiliation	University of Maryland School of Medicine

Center for Vaccine Development and Global Health is a biomedical research center affiliated with the University of Maryland School of Medicine focused on vaccine research, infectious disease control, and global health interventions. The center conducts translational research, clinical trials, and capacity-building projects in collaboration with international partners such as World Health Organization, Centers for Disease Control and Prevention, Bill & Melinda Gates Foundation, Gavi, the Vaccine Alliance, and national ministries of health. Its mission aligns with initiatives from organizations like National Institutes of Health, Wellcome Trust, Coalition for Epidemic Preparedness Innovations, Pan American Health Organization, and regional research networks.

History

The center traces roots to academic programs within the University of Maryland, Baltimore and collaborations with institutions including Johns Hopkins University, Walter Reed Army Institute of Research, National Institute of Allergy and Infectious Diseases, Fogarty International Center, and the U.S. Department of Health and Human Services. Early projects connected investigators from Harvard University, Stanford University, Columbia University, University of Oxford, and London School of Hygiene & Tropical Medicine on vaccine design for pathogens studied by Centers for Disease Control and Prevention and global partners like Médecins Sans Frontières and PATH. Over decades the center expanded partnerships with field sites in countries such as Malawi, Nepal, Pakistan, Bangladesh, Peru, Ghana, Kenya, Tanzania, and Thailand, and engaged with funding agencies including Howard Hughes Medical Institute, European Commission, Japan International Cooperation Agency, and Australian Department of Foreign Affairs and Trade.

Research and Programs

Research programs span immunology, epidemiology, microbiology, and clinical sciences, linking investigators from National Institute of Child Health and Human Development, Bill & Melinda Gates Foundation, European Molecular Biology Laboratory, Institut Pasteur, and Chinese Center for Disease Control and Prevention. Projects address pathogens prioritized by World Health Organization lists and involve technologies from teams at Massachusetts Institute of Technology, California Institute of Technology, Broad Institute, Scripps Research Institute, and Dana-Farber Cancer Institute. Programs incorporate surveillance activities with partners such as Global Fund to Fight AIDS, Tuberculosis and Malaria, African Union, Southeast Asia Infectious Disease Clinical Research Network, and public health agencies including Public Health England and Health Canada.

Clinical Trials and Vaccine Development

The center conducts phase I–III clinical trials in collaboration with regulatory authorities like the Food and Drug Administration (United States), ethics boards from institutions such as Institutional Review Board, and global trial networks including International Vaccine Institute, Human Vaccines Project, European Vaccine Initiative, and African Vaccine Regulatory Forum. Vaccine candidates evaluated have origins in research from University of Oxford, Moderna, Inc., AstraZeneca, Pfizer, Novavax, and academic groups at Yale University, University of Pennsylvania, University of California, San Diego, and Emory University. Clinical sites coordinate with local ministries in nations such as Mozambique, Rwanda, Uganda, Sri Lanka, Cambodia, and Ecuador and report findings to peer venues like The Lancet, New England Journal of Medicine, Nature Medicine, Science Translational Medicine, and PLOS Medicine.

Education and Training

Training programs connect faculty and trainees from University of Maryland, Baltimore County, Johns Hopkins Bloomberg School of Public Health, George Washington University, Georgetown University, and Howard University with international fellows from Makerere University, University of Nairobi, Addis Ababa University, University of Zambia, and University of the West Indies. Curriculum and workshops have been co-developed with entities including WHO Regional Office for Africa, Centers for Disease Control and Prevention, United States Agency for International Development, UK Department for International Development, and professional societies like Infectious Diseases Society of America and American Society for Microbiology.

Partnerships and Global Health Initiatives

The center’s partnerships include multilateral collaborations with World Health Organization, UNICEF, Gavi, the Vaccine Alliance, Global Fund, and bilateral projects supported by National Institutes of Health, USAID, European Commission, Wellcome Trust, and philanthropic organizations such as Gates Foundation and Rockefeller Foundation. It participates in consortia with academic and corporate partners including University of Oxford, AstraZeneca, Moderna, Inc., Novavax, Pfizer, Merck & Co., Sanofi, and regional research networks like the Asian Health Network and African CDC initiatives.

Facilities and Funding

Physical facilities include laboratories and clinical research units located on the University of Maryland School of Medicine campus and affiliated field stations in sites across Africa, Asia, and Latin America, with infrastructure supported by grants from National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, European Research Council, and corporate partnerships with Pfizer, Moderna, Inc., AstraZeneca, Merck & Co., and Sanofi. Financial oversight and grant management interact with agencies such as the National Science Foundation, Office of the Director of National Intelligence for biosecurity coordination, and institutional partners including Johns Hopkins University and University of Oxford to sustain long-term research and training commitments.

Category:Vaccine research institutes